EUVIMEDEUVIMED entdecken
Crossref

Endoscopic ablation of focal pancreatic lesions

E Bella, K Pawlak, P Kaczor, J Piątkowski, M Jackowski, M Jagielski

Endoscopy · 01.06.2026 · 58 (S 03 S 03) · S794

DOI: 10.1055/s-0046-1822211 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.06.2026. Verfasst von E Bella und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

To assess the effectiveness and safety of EUS-guided endoscopic ablation of focal pancreatic lesions.

Methods

A prospective assessment of treatment outcomes of all patients in whom EUS-guided ablation of a focal pancreatic lesion was performed between 2019 and 2025 at the Department of General, Gastroenterological and Oncological Surgery, Collegium Medicum, Nicolaus Copernicus University in Toruń.

Results

Endoscopic ablation of 26 focal pancreatic lesions was performed in 21 patients (14 women, 7 men; mean age 39.77 [21–75] years). Seventeen patients had solitary lesions, and four had multifocal lesions. Eight lesions were located in the pancreatic head, 12 in the body, and 6 in the tail. Histopathology revealed G1 neuroendocrine tumors in 14 patients, while in the remaining 7 patients metastatic renal cell carcinoma or breast cancer lesions were identified. The mean size of the focal lesions was 11 (7–20) mm. In 9 patients, EUS-guided radiofrequency ablation (EUS-RFA) of 12 pancreatic lesions was performed. In 12 patients, ablation of 14 lesions using 98% ethanol was carried out. Technical success was achieved in 23/26 (88.46%) lesions in 19/21 (90.48%) patients. Complications occurred in 4/21 (19.05%) patients. The mean follow-up was 864 (88–1464) days. Long-term success was achieved in 17/21 (80.95%) patients.

Conclusions

EUS-guided endoscopic ablation of focal pancreatic lesions is an effective and safe treatment option in selected patients and represents an alternative to surgical management. Publication History Article published online: 05 June 2026 © 2026. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

Zitieren

APA

Bella, E., Pawlak, K., Kaczor, P., Piątkowski, J., Jackowski, M., & Jagielski, M. (2026). Endoscopic ablation of focal pancreatic lesions. Endoscopy, 58(S 03 S 03), S794. https://doi.org/10.1055/s-0046-1822211

Vancouver

Bella E, Pawlak K, Kaczor P, Piątkowski J, Jackowski M, Jagielski M. Endoscopic ablation of focal pancreatic lesions. Endoscopy. 2026;58(S 03 S 03):S794. doi:10.1055/s-0046-1822211

BibTeX
@article{Bella2026,
  author = {Bella, E and Pawlak, K and Kaczor, P and Piątkowski, J and Jackowski, M and Jagielski, M},
  title = {Endoscopic ablation of focal pancreatic lesions},
  journal = {Endoscopy},
  year = {2026},
  volume = {58},
  number = {S 03 S 03},
  pages = {S794},
  doi = {10.1055/s-0046-1822211}
}
Kostenlos starten →